Tert-butyl 2-[(2S)-4-(3-cyclopropylphenyl)sulfonyl-2-(3-oxobutyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetate
C27H33NO6S — CID 159941470
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 2-[(2S)-4-(3-cyclopropylphenyl)sulfonyl-2-(3-oxobutyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetate
Tert-butyl 2-[(2S)-4-(3-cyclopropylphenyl)sulfonyl-2-(3-oxobutyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetate (PubChem CID 159941470) has the molecular formula C27H33NO6S and a molecular weight of 499.63 g/mol. Its IUPAC name is tert-butyl 2-[(2S)-4-(3-cyclopropylphenyl)sulfonyl-2-(3-oxobutyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetate.
Molecular Properties
| Compound Name | Tert-butyl 2-[(2S)-4-(3-cyclopropylphenyl)sulfonyl-2-(3-oxobutyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetate |
|---|---|
| PubChem CID | 159941470 |
| Molecular Formula | C27H33NO6S |
| Molecular Weight | 499.63 g/mol |
| Exact Mass | 499.20 |
| IUPAC Name | tert-butyl 2-[(2S)-4-(3-cyclopropylphenyl)sulfonyl-2-(3-oxobutyl)-2,3-dihydro-1,4-benzoxazin-6-yl]acetate |
| SMILES | CC(=O)CC[C@H]1CN(S(=O)(=O)c2cccc(C3CC3)c2)c2cc(CC(=O)OC(C)(C)C)ccc2O1 |
| InChI | InChI=1S/C27H33NO6S/c1-18(29)8-12-22-17-28(35(31,32)23-7-5-6-21(16-23)20-10-11-20)24-14-19(9-13-25(24)33-22)15-26(30)34-27(2,3)4/h5-7,9,13-14,16,20,22H,8,10-12,15,17H2,1-4H3/t22-/m0/s1 |
| InChIKey | OAXYXNOHUJACAB-QFIPXVFZSA-N |
| XLogP | 4.77 |
| TPSA | 89.98 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 499.63 |
| LogP ≤ 5 | 4.77 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159941470 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.